The one exception to the day's modest share price movement, was Neurochem, which rose after the company said it had an $80 million cash position. The company's stock recently plunged on a failed Alzheimer's drug candidate study. But shares jumped $1.44, or 43.2 percent, to $4.71 Wednesday.
Market Data 
Markets 
AI
